Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4003319 | American Journal of Ophthalmology | 2012 | 8 Pages |
Abstract
This pilot interventional study shows that a 5-day course of antioxidant and zinc supplements can modify plasma levels of CySS, suggesting that this oxidative stress biomarker could help predict how likely an individual is to benefit from AREDS supplementation. Further, CySS may be useful for the evaluation of new AMD therapies, particularly those hypothesized to affect redox status.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Milam A. Jr, Melissa P. Osborn, Barton J. Sanders, Kasra A. Rezaei, Pengcheng Lu, Chun Li, Ginger L. Milne, Jiyang Cai, Paul Jr,